2020
DOI: 10.1016/j.arabjc.2017.09.009
|View full text |Cite
|
Sign up to set email alerts
|

3D-QSAR, docking, molecular dynamics simulation and free energy calculation studies of some pyrimidine derivatives as novel JAK3 inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
12
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 40 publications
(13 citation statements)
references
References 65 publications
1
12
0
Order By: Relevance
“…The sequence and structure of the kinase domains of the four members of JAK family are highly similar; however, they are still slightly different in the amino acids nearby the inhibitor binding sites. Certain studies have shown that the covalent binding between JAK3 Cys909 and inhibitor may be an excellent attempt . It also provides direction for the structural modification of CE for the improvement of its binding ability with JAK3 protein in the future.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The sequence and structure of the kinase domains of the four members of JAK family are highly similar; however, they are still slightly different in the amino acids nearby the inhibitor binding sites. Certain studies have shown that the covalent binding between JAK3 Cys909 and inhibitor may be an excellent attempt . It also provides direction for the structural modification of CE for the improvement of its binding ability with JAK3 protein in the future.…”
Section: Discussionmentioning
confidence: 99%
“…Certain studies have shown that the covalent binding between JAK3 Cys909 and inhibitor may be an excellent attempt. 65 It also provides direction for the structural modification of CE for the improvement of its binding ability with JAK3 protein in the future. Pharmacokinetics is the digital representation of the changes of drugs after entering the human body, which can provide guidance for the use of drugs.…”
Section: â–  Discussionmentioning
confidence: 99%
“…2. It can be concluded that the model presents relatively high predictive power, as the model satis ed the external and internal validation criteria: R 2 > 0.6, Q 2 LMO and Q 2 LOO > 0.5, CCC > 0.85, Q 2 F1 , Q 2 F2 and Q 2 F3 > 0.6, r 2 m > 0.5, â–³r 2 m < 0.2 and 0.85 ≤ k ≤ 1.15 or 0.85 ≤ k′ ≤ 1.15 (Balupuri et al 2020). The difference between R 2 and Q 2 LOO is 0.11 units, less than 0.2, indicating the absence of over ting (Kiralj and Ferreira 2009).…”
Section: D-qsar Modelmentioning
confidence: 99%
“…The calculation process using the MM-GBSA method provided some information about the complete energy components in the gas state (eqn (18)) and the solvation state (eqn (19)). The candidates that gave good results were evaluated by comparing them with the binding free energy of the native ligand as a benchmark for the criterion of DG candidate ligand < DG native ligand.…”
Section: Molecular Docking and Molecular Dynamic Simulationmentioning
confidence: 99%
“…[14][15][16][17] Several computational chemistry techniques developed for drug design, such as Molecular Docking (MD) and Molecular Dynamic Simulation (MDS), using in silico approaches have shown very good accuracy in studying interactions between drugs and protein targets. 18,19 Molecular docking has shown good performance in studying the initial coordinates of drug interactions (ligands) with protein targets (receptor). 20 Additionally, molecular dynamic simulation can predict the free energy of ligand-receptor binding by using the Molecular Mechanics-Generalized Born Surface Area (MM-GBSA) method that has been widely used.…”
Section: Introductionmentioning
confidence: 99%